Clinical trial

Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Newly…

NCT00003625 · Children's Oncology Group, Other · Completed

Key facts

NCT number NCT00003625
Title Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Newly Diagnosed Brain Stem Glioma
Official title Vincristine, Etoposide and Cyclosporine A in Concert With Standard Dose Radiation Therapy in Diffuse Intrinsic Brain Stem Glioma - A Phase I Study of Dose Escalation of Vincristine
Lead sponsor Children's Oncology Group, Other
Collaborators National Cancer Institute (NCI) NIH
Status Completed
Phase Phase 1
Study type Interventional
Conditions Brain Tumors, Central Nervous System Tumors
Intervention type Drug, Radiation
Interventions cyclosporine, etoposide, vincristine sulfate, radiation therapy
Enrollment 7
Start date Dec 1, 1998
Primary completion Feb 1, 2001
Completion Apr 1, 2006
First posted Sep 13, 2004
Last update posted Jul 28, 2014
Countries Canada, Netherlands, Puerto Rico, Switzerland, United States

At a glance

  • 10–99 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies